The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Medmira Inc

  • MIR
  • TSX Venture
  • Consumer Products
  • Latest 0.08
  • Currency C$
  • Change 0.0000
  • Percent Change 0.00 %
  • Volume 8,500
  • Tue Apr 15, 2014 03:29 PM EDT TSX Venture data delayed 15 minutes.
  • Open 0.08
  • Previous Close 0.08
  • High 0.08
  • Low 0.08
  • Bidx119,000 0.08
  • Askx64,000 0.085
  • 52-week High01/29 0.14
  • 52-week Low11/01 0.045
  • Beta 0.546
  • Market Cap 20.18M
  • EPS -0.02
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $1,441,403
  • Earnings $-4,892,183
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-3,435,831
  • Cash $1,026,763
  • Current Ratio 0.07

12 months ended Jul 31, 2011.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $1,492,123
  • Liabilities $20,605,822
  • Liabilities-to-Equity Ratio n/a

Price Ratios

  • Price to Sales 20.00
  • Price to Book n/a
  • Price to Cash Flow -5.00

Event Calendar

Event Last   Next  
Earnings Apr 2 n/a n/a n/a
Surprises n/a n/a n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 16, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

MEDMIRA INC. is a developer and manufacturer of rapid diagnostic technology and solutions.

Related Securities
Symbol Type Latest % Chg

Officers

  • Hermes Chan C.E.O.
  • Daniel Frid C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: n/a
  • Incorporation: Canada,
    Jul 26, 1999
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

Suite 1
Halifax, NS
B3S 1B3

Phone: (902)-450-1588
Fax: (902)-4501580

ir@medmira.com
www.medmira.com

Ideas & Discussion

Live Discussion of MIR on StockTwits